39. SYSTEMATIC REVIEW OF THE EFFICARY, SAFETY AND COST-EFFECTIVENESS OF MIRABEGRON IN COMPARISON WITH SOLIFENACIN IN THE TREATMENT OF OVERACTIVE BLADDER. YHCĐ. 2024;65(CĐ 7 - NCKH). doi:10.52163/yhc.v65iCD7.1334